newsfilter
← Latest News
Business Wire·

PharmaCyte Biotech Reaches Cooperation Agreement with Iroquois Capital

Company Appoints Five New Independent Directors to Reconstituted Board PharmaCyte Biotech, Inc. (NASDAQ:PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes and malignant ascites using its signature live-cell e